At a panel at CTO West Coast, experts from biopharmaceutical companies outlined innovative strategies to shape the future of ...

However, the protocol and patient-facing materials must still be tailored to each individual trial. A single IMPD can support multiple trials using the same investigational product, but a fully ...

Tracking the trajectory of symptoms may be an improvement over the traditional way of collecting patient-reported outcomes ...

What is most important for patients is knowledge about and access to clinical trials, so they have the opportunity to participate if they choose and can make informed decisions about their health. The ...

Background: Patient complaints are viewed as indications of dissatisfaction with the service received or experience at a health care institution. The prediction of patient complaints is not clearly ...

In the past, if an NIH-funded clinical trial needed to halt—in an instance of, say, misconduct or clear harm to patients—the agency could be counted on to provide money and support to ensure ...